Showing results (21-30 of 471) with videos related to

Sort By:
Pageof 48
Hepatology (Baltimore, Md.)|November 25, 2010
Therapeutic trials in nonalcoholic steatohepatitis: insulin sensitizers and related methodological issuesVlad Ratziu, Stephen Caldwell, Brent A Neuschwander-Tetri
Comparative Hepatology|January 13, 2006
Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutantVlad Ratziu, Vincent Thibault, Yves Benhamou, et al.
Pancreas|September 16, 2005
Chronic calcifying pancreatitis and systemic lupus erythematousHassane Izzedine, Caroline Caramella, Vlad Ratziu, et al.
Biomarkers in Medicine|May 19, 2010
Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?Vlad Ratziu, Laurence Martin, Larysa Fedchuk, et al.
Expert Review of Gastroenterology & Hepatology|April 12, 2011
Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies?Amedeo Lonardo, Stefano Bellentani, Vlad Ratziu, et al.
Human Pathology|January 7, 2003
Portal lymphocytic infiltrate in alcoholic liver diseaseMagali Colombat, Frédéric Charlotte, Vlad Ratziu, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|October 29, 2009
Diagnosis and treatment of viral liver fibrosisThierry Poynard, Francoise Imbert-Bismut, Mona Munteanu, et al.
Expert Review of Molecular Diagnostics|February 23, 2005
FibroTest-FibroSURE: towards a universal biomarker of liver fibrosis?Thierry Poynard, Françoise Imbert-Bismut, Mona Munteanu, et al.
Journal of Hepatology|September 26, 2008
Hepatitis C infection and risk of diabetes: a systematic review and meta-analysisDonna L White, Vlad Ratziu, Hashem B El-Serag
Hepatology International|February 21, 2019
End-points for drug treatment in NASHLeon A Adams
Pageof 48